J. Donohue

发表

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee

Stanley B. Cohen, D. Burstein, Yu‐Nien Sun, 2011, Arthritis research & therapy.

Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

L. Einhorn, J. Donohue, 1977, Annals of internal medicine.

Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan).

M. Weinberger, J. Pratt, D. Henry, 1979, The American journal of medicine.

Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings.

I. Leibovitch, J. Donohue, R. Bihrle, 1995, Urology.

Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy

T. Ulbright, J. Donohue, R. Foster, 1994, World Journal of Urology.

Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy.

T. Ulbright, J. Donohue, J. Donohue, 1994, The Journal of urology.

Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node Dissection

J. Baniel, J. Donohue, R. Bihrle, 1995 .

The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.

L. Einhorn, J. Messemer, S. Saxman, 1996, The Journal of urology.

Surgery for Germ Cell Tumours: Current Status in the USA

J. Donohue, R. Bihrle, R. Foster, 2002 .

Outcomes in Patients with Testicular Maldescent and Germ Cell Neoplasia: A Retrospective Assessment and Review of the Literature

Jeffrey A Jones, J. Donohue, G. Godoy, 2018, Urology and Andrology – Open Journal.

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.

T. Ulbright, L. Einhorn, J. Donohue, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors.

L. Einhorn, D. Heilman, J. Donohue, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer.

K. Kopecky, L. Einhorn, J. Donohue, 1987, The Journal of urology.

Improved chemotherapy in disseminated testicular cancer.

L. Einhorn, J. Donohue, J. Donohue, 1977, The Journal of urology.

Recurrent testis cancer: seeding from retroperitoneal nodes after complete remissions by chemotherapy.

L. Einhorn, J. Donohue, R. Rowland, 1983, The Journal of urology.

Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.

T. Ulbright, L. Einhorn, S. Clark, 1986, The Journal of urology.

Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

L. Einhorn, J. Donohue, J. Donohue, 1977, Annals of internal medicine.

Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study.

J. Ellis, D. Stablein, R. Weiss, 1991, The Journal of urology.

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

J. Thornhill, J. Donohue, J. Donohue, 1993, British journal of urology.

Surgery in advanced disease for testicular cancer.

F. Debruyne, W. Hendry, J. Donohue, 1990, Progress in clinical and biological research.

Hepatic Resection for Disseminated Germ Cell Carcinoma

L. Einhorn, P. Loehrer, J. Donohue, 1990, Annals of surgery.

Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy.

L. Einhorn, J. Donohue, J. Donohue, 1982, The Journal of urology.

Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma.

J. Donohue, R. Bihrle, R. Foster, 1994, The Journal of urology.

Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.

J. Donohue, J. Donohue, R. Bihrle, 1996, The Journal of urology.

Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.

L. Einhorn, D. Heilman, C. Sweeney, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment.

P. Albers, K. Kopecky, T. Ulbright, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adult primary pure teratoma of the testis. The Indiana experience

T. Ulbright, I. Leibovitch, J. Donohue, 1995, Cancer.

Evolving concepts in surgical management of testis cancer.

J. Donohue, R. Bihrle, R. Foster, 1992, Cancer treatment and research.

Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.

L. Einhorn, J. Donohue, P. Loehrer, 1986, The Journal of thoracic and cardiovascular surgery.

Integration of surgery and systemic therapy: results and principles of integration.

J. Donohue, J. Baniel, J. Donohue, 1998, Seminars in urologic oncology.

Teratoma in the Orchiectomy Specimen and Volume of Metastasis are Predictors of Retroperitoneal Teratoma in Post-Chemotherapy Nonseminomatous Testis Cancer

T. Ulbright, L. Einhorn, M. Koch, 1996 .

Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.

E. Steyerberg, S. Fosså, H. Keizer, 1997, The Journal of urology.

Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent.

L. Einhorn, J. Donohue, S. Williams, 1980, The Journal of urology.

cis-Platinum combination chemotherapy of bladder cancer: an update.

L. Einhorn, S. Williams, J. Donohue, 1979, Cancer clinical trials.

Improved management of nonseminomatous testis tumors

J. Donohue, L. H. Einhorn, J. M. Pérez, 1978, Cancer.

Malignant testicular neoplasms in immunosuppressed patients.

I. Leibovitch, J. Baniel, J. Donohue, 1996, The Journal of urology.

Late relapse of clinical stage I testicular cancer.

L. Einhorn, J. Baniel, J. Donohue, 1995, The Journal of urology.

Late relapse of testicular cancer.

L. Einhorn, J. Messemer, R. Gonin, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary aldosteronism: diagnosis, localization, and treatment.

M. Weinberger, D. Kem, J. Hollifield, 1979, Annals of internal medicine.

Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors

T. Ulbright, T. Senge, J. Messemer, 2004, Urological Research.

Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?

B. Leibovich, J. Donohue, R. Bihrle, 2003, The Journal of urology.

Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?

J. Donohue, J. Donohue, R. Foster, 1998, The Urologic clinics of North America.

Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.

L. Einhorn, B. Roth, J. Donohue, 1998, Urology.

The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).

J. Richie, L. Einhorn, J. Thornhill, 1995, The Journal of urology.

Complications of primary retroperitoneal lymph node dissection.

J. Donohue, J. Baniel, J. Donohue, 1994, The Journal of urology.

Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.

J. Thornhill, J. Donohue, R. Bihrle, 1993, The Journal of urology.

Surgical salvage of chemorefractory germ cell tumors.

L. Einhorn, W. Walsh, J. Messemer, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immediate Adjuvant Chemotherapy Versus Observation With Treatment at Relapse in Pathological Stage II Testicular Cancer

D. Stablein, L. Einhorn, E. Crawford, 1988 .

Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.

L. Einhorn, J. Donohue, R. Bihrle, 2005, Urologic oncology.

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.

D. Stablein, L. Einhorn, R. Weiss, 1987, The New England journal of medicine.

Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.

C. Sweeney, J. Donohue, J. Donohue, 2000, The Journal of urology.

Results a nd O utcome o f R etroperitoneal L ymph N ode Dissection f or C linical S tage I E mbryonal Carcinoma-Predom inant T estis C ancer

L. Einhorn, D. Heilman, C. Sweeney, 2000 .

NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTION

C. Sweeney, J. Donohue, R. Foster, 2000 .

Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer.

L. Einhorn, S. Williams, J. Donohue, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?

L. Einhorn, J. Donohue, R. Bihrle, 2007, Cancer.

Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.

M. Koch, J. Donohue, R. Bihrle, 2004, The Journal of urology.

Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.

J. Donohue, M. Koch, J. Donohue, 2001, The Journal of urology.

En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.

J. Donohue, I. Leibovitch, J. Donohue, 1998, The Journal of urology.

Complications of post-chemotherapy retroperitoneal lymph node dissection.

J. Baniel, J. Donohue, R. Bihrle, 1995, The Journal of urology.

Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava.

J. Thornhill, J. Donohue, R. Bihrle, 1994, World journal of urology.

Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II.

J. Thornhill, J. Donohue, R. Bihrle, 1994, World journal of urology.

Resection of the inferior vena cava or intraluminal vena caval tumor thrombectomy during retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and results.

J. Thornhill, J. Donohue, R. Bihrle, 1991, The Journal of urology.

Complications of retroperitoneal lymph node dissection.

J. Donohue, J. Donohue, R. Bihrle, 1981, The Journal of urology.

Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors

B. Roth, J. Baniel, J. Donohue, 1995, Cancer.

Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.

L. Einhorn, J. Donohue, R. Bihrle, 2007, The Urologic clinics of North America.

Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.

L. Einhorn, J. Donohue, R. Bihrle, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Seminar article Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer

L. Einhorn, J. Donohue, R. Bihrle, 2005 .

Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.

K. Kopecky, J. Donohue, J. Donohue, 1995, The Journal of urology.

Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.

L. Einhorn, J. Donohue, R. Foster, 2000, European journal of cancer.

Comparison of NMR and CT Imaging in the Evaluation of Metastatic Retroperitoneal Lymphadenopathy from Testicular Carcinoma

J. Ellis, K. Kopecky, J. Donohue, 1984, Journal of computer assisted tomography.

Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.

J. Donohue, R. Bihrle, R. Foster, 2007, Urology.

Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.

J. Donohue, R. Foster, J. Donohue, 2000, The Journal of urology.

Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors

P. Albers, T. Ulbright, W. D. de Riese, 1994, Cancer.

Retroperitoneal lymphadenectomy for clinical stage a testis cancer: Modifications of technique and impact on ejaculation

J. Donohue, R. Foster, 1994 .

Unsolved problems in testis cancer.

J. Donohue, 1993, European urology.

Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors

B. Roth, J. Baniel, J. Donohue, 2006, Annals of Surgical Oncology.

Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques.

J. Donohue, R. Foster, 1998, The Urologic clinics of North America.

Distribution of nodal metastases in nonseminomatous testis cancer.

J. Donohue, J. Donohue, J. Zachary, 1982, The Journal of urology.

Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection.

J. Thornhill, J. Donohue, J. Donohue, 1995, European journal of cancer.

Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up

P. Albers, T. Ulbright, J. Donohue, 2004, Urological Research.

Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.

O. Cummings, P. Albers, J. Donohue, 1995, European journal of cancer.

Germ cell tumor associated primitive neuroectodermal tumors.

H. Michael, L. Einhorn, K. Ganjoo, 2001, The Journal of urology.

Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis

T. Ulbright, L. Einhorn, P. Loehrer, 1994, World Journal of Urology.

Vascular considerations in postchemotherapy

J. Thornhill, J. Donohue, R. Bihrle, 1994, World Journal of Urology.

Vascular considerations in postchemotherapy

J. Thornhill, J. Donohue, R. Bihrle, 1994, World Journal of Urology.

Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer.

J. Donohue, I. Leibovitch, J. Donohue, 1996, The Journal of urology.

Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.

J. Donohue, J. Baniel, J. Donohue, 1993, The Journal of urology.

Incidental appendectomy during urological surgery.

I. Leibovitch, J. Donohue, R. Rowland, 1995, The Journal of urology.

Bilateral testicular tumors

B. Roth, J. Donohue, R. Foster, 1998, Cancer.

Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.

T. Ulbright, L. Einhorn, M. Koch, 2002, The Journal of urology.

Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT): the development of nerve-sparing techniques.

J. Donohue, 1996, Cancer treatment and research.

Flow‐cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical‐stage‐I non‐seminomatous testicular germ‐cell tumors

Jeffrey A Jones, P. Albers, T. Ulbright, 1994, International journal of cancer.

Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology.

P. McGraw, L. Einhorn, D. Heilman, 1998, The Journal of urology.

Renal Vascular Hypertension

M. Weinberger, J. Donohue, C. Grim, 1986 .

Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma.

K. Kopecky, I. Leibovitch, J. Donohue, 1995, The Journal of urology.

Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia.

M. Weinberger, J. Pratt, J. Donohue, 1993, The Journal of urology.

Results of surgical treatment of renovascular hypertension.

M. Weinberger, J. Donohue, C. Grim, 1979, The Journal of urology.

Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release.

A. Melman, M. Weinberger, J. Donohue, 1977, The Journal of urology.

Possible mechanism of hypoglycemia following removal of pheochromocytoma.

A. Sagalowsky, J. Donohue, 1980, The Journal of urology.

Does retroperitoneal lymph node dissection have a curative role for patients with sex cord–stromal testicular tumors?

T. Ulbright, L. Einhorn, M. Koch, 2003, Cancer.

Observations on renal mass in experimental hypertension.

J. Donohue, 1966, The Journal of urology.

Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?

Liang Cheng, J. Donohue, R. Bihrle, 2005, The Journal of urology.

[Nerve sparing retroperitoneal lymphadenectomy (RLA)].

P. Albers, J. Donohue, R. Foster, 2010, Aktuelle Urologie.

A randomized , double-blind study of AMG 108 ( a fully human monoclonal antibody to IL-1 R 1 ) in patients with osteoarthritis of the knee

Stanley B. Cohen, D. Burstein, Yu‐Nien Sun, 2011 .

Advanced testicular cancer: update for urologists.

L. Einhorn, J. Donohue, 1998, The Journal of urology.

Occlusion of the artery to a solitary kidney. Restoration of renal function after prolonged anuria.

R. Hamburger, J. Donohue, C. Grim, 1974, JAMA.

Bacterial endocarditis in chronic hemodialysis patients: a complication more common than previously suspected.

J. Glover, J. Donohue, L. H. King, 1971, Surgery.

Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer

J. Baniel, J. Donohue, R. Bihrle, 2004, World Journal of Urology.

Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.

I. Leibovitch, J. Baniel, J. Donohue, 1996, The Journal of urology.

Radiology in primary hyperaldosteronism.

M. Weinberger, H. Wellman, J. Donohue, 1976, AJR. American journal of roentgenology.

Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases

H. Michael, T. Ulbright, P. Loehrer, 1990, Cancer.

Biology of metastases and its clinical implications: testicular germ-cell tumors

J. Donohue, P. Loehrer, J. Donohue, 2004, World Journal of Urology.

The significance of atypia within teratomatous metastases after chemotherapy for malignant germ cell tumors

T. Ulbright, L. Einhorn, D. Davey, 1987, Cancer.

Improved management of non-seminomatous testis tumors.

L. Einhorn, J. Donohue, J. M. Perez, 1979, The Journal of urology.

Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997.

L. Einhorn, J. Donohue, 2002, The Journal of urology.

Stage I nonseminomatous germ-cell testicular cancer — management options and risk-benefit considerations

J. Thornhill, J. Donohue, R. Bihrle, 1994, World Journal of Urology.

Cytoreductive surgery in testicular cancer

J. Donohue, R. Rowland, 1984, World Journal of Urology.

Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors.

J. Donohue, I. Leibovitch, J. Donohue, 1996, The Journal of urology.

Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.

L. Einhorn, J. Donohue, R. Bihrle, 2007, The Journal of urology.

Surgical anatomy of the lumbar vessels: implications for retroperitoneal surgery.

J. Baniel, J. Donohue, R. Foster, 1995, The Journal of urology.

Angiomyolipoma: emerging concepts in management.

J. Lingeman, J. Donohue, J. Madura, 1982, Urology.

High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience.

J P Donohue, P. J. Hood, N. Sanghvi, 1994, The Journal of urology.

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

L. Einhorn, S. Williams, J. Donohue, 1981, Cancer.

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

J P Donohue, E W Steyerberg, H Schraffordt Koops, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy of disseminated testicular cancer.

L. Einhorn, J. Donohue, 1985, Nihon Gan Chiryo Gakkai shi.

Combination chemotherapy in disseminated testicular cancer: the Indiana University experience.

L. Einhorn, J. Donohue, J. Donohue, 1979, Seminars in oncology.

Acute Versus Chronic Experimental Hypertension: The Difference in Pressor Response to Partial Nephrectomy

J. Donohue, 1969 .

The Current Management of Neuroblastoma

J. Donohue, J. Grosfeld, R. Baehner, 1980 .

Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.

P. Albers, T. Ulbright, J. Baniel, 1996, The Journal of urology.

Selecting initial therapy. Seminoma and nonseminoma

J. Donohue, 1987, Cancer.

Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation.

J. Donohue, J. Donohue, R. Bihrle, 1990, The Journal of urology.

Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors.

L. Einhorn, J. Donohue, S. Williams, 1982, The Journal of urology.

The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer.

J. Donohue, I. Leibovitch, J. Baniel, 1995, The Journal of urology.

Histology in mixed germ cell tumors. Is there a favorite pairing?

B. Leibovich, T. Ulbright, L. Einhorn, 2004, The Journal of urology.

Disseminated seminoma: re-evaluation of treatment protocols.

L. Einhorn, S. Williams, J. Donohue, 1981, The Journal of urology.

Clinical stage I pure yolk sac tumor of the testis in adults has different clinical behavior than juvenile yolk sac tumor.

J. Donohue, R. Bihrle, R. Foster, 2000, The Journal of urology.

Treatment of local regional disease.

J. Donohue, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Mucosal T Lymphocyte Numbers Are Selectively Reduced in Integrin αE (CD103)-Deficient Mice

D. Beier, E. A. Murphy, M. Schön, 1999, The Journal of Immunology.

Sixteen-year survival with metastatic signet ring cell bladder carcinoma.

A. Sagalowsky, J. Donohue, 1980, Urology.

Primary Aldosteronism: Pathophysiology, Diagnosis and Treatment

J. Donohue, A. Ganguly, A. Ganguly, 1983 .

Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism.

M. Weinberger, J. Pratt, J. Donohue, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Metastatic renal embryoma: survival following therapy.

J. Donohue, R. Garrett, T. L. Arnold, 1967, The Journal of urology.

AN EVALUATION OF VOIDING CYSTOMETRY AS A DIAGNOSTIC TEST FOR BLADDER OUTLET OBSTRUCTION.

J. Donohue, G. Leadbetter, 1964, The Journal of urology.

The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.

T. Ulbright, J. Eble, J. Messemer, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy.

J. Donohue, P. Nash, R. Foster, 1996, British journal of urology.

Adrenalectomy via the dorsal approach: a benchmark for laparoscopic adrenalectomy.

I. Leibovitch, J. Donohue, P. Nash, 1995, The Journal of urology.

Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).

J. Donohue, 2003, Urologic oncology.

Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.

Liang Cheng, T. Ulbright, J. Donohue, 2005, The Journal of urology.

The multiple manifestations of neuroblastoma.

J. Donohue, R. Baehner, R. Garrett, 1974, The Journal of urology.

Juxtaglomerular cells in renal angiomyolipoma. Ultrastructural observation.

J. Donohue, M. Yum, A. Ganguly, 1984, Urology.

Bilateral Wilms tumors.

J. Donohue, R. Garrett, 1978, The Journal of urology.

Tissue typing for transplantation: a progress report.

J. Donohue, A. Biegel, 1970, The Journal of urology.

Pheochromocytoma presenting as middeldorpf tumor: case report.

M. Weinberger, J. Donohue, J. M. Perez, 1978, The Journal of urology.

Rehabilitation in ankylosing spondylitis

J. Donohue, F. T. Nghiem, 2008, Current opinion in rheumatology.

Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer.

J. Habbema, E. Steyerberg, Y. Vergouwe, 2001, The Journal of urology.

Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.

D. Beier, E. A. Murphy, M. Schön, 1999, Journal of immunology.

591: Do Postchemotherapy Patients who Present with an Elevated Serum AFP and Pure Seminoma in the Orchiectomy Specimen Have a Higher Probability of Finding Necrosis only in the Retroperitoneal Lymph Node Dissection (RPLND) Specimen?

L. Einhorn, M. Peterson, J. Donohue, 2006 .

Cutaneous Inflammatory Disorder in Integrin αE (CD103)-Deficient Mice1

M. Schön, M. Schön, J. Donohue, 2000, The Journal of Immunology.

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor

J. Habbema, E. Steyerberg, S. Fosså, 1997, Cancer.

Obscure abdominal distress and vascular collapse in a man.

J. Donohue, R. Garrett, K. Warfel, 1979, Journal of Urology.

The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer.

L. Einhorn, S. Williams, J. Donohue, 1983, The Annals of thoracic surgery.

Combined Urologic and Thoracic Approaches for Advanced or Disseminated Testis Cancer

K. Kesler, J. Donohue, 1999 .

Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice.

M. Schön, M. Schön, H. Warren, 2000, Journal of immunology.

Hyperaldosteronism due to unsuspected adrenal carcinoma: discovery during investigation of hypertension in a young woman.

M. Weinberger, J. Donohue, C. Grim, 1981, The Journal of urology.

Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.

M. Peterson, J. Donohue, R. Bihrle, 2007, The Journal of urology.

Ureteroneocystostomy versus ureteropyelostomy: a comparison in the same renal allograft series.

M. Hostetter, J. Glover, J. Donohue, 1975, Journal of Urology.

Bilateral nephrectomy: its role in management of the malignant hypertension of end-stage renal disease.

J. Donohue, K. P. Bradley, D. Shires, 1971, The Journal of urology.

Percutaneous transluminal angioplasty for renal artery stenosis in a solitary functioning kidney.

F. Luft, M. Weinberger, J. Donohue, 1979, Annals of internal medicine.

Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer.

I. Leibovitch, J. Baniel, J. Donohue, 1995, The Journal of urology.

High-intensity focused ultrasound for the treatment of benign prostatic hypertrophy.

N. Sanghvi, J. Donohue, R. Bihrle, 1994, Seminars in urology.

Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?

L. Einhorn, S. Little, A. Sandler, 1998, The Journal of urology.

Micro-penis following Badenoch pull-through procedure: a case report.

J. Donohue, R. Judd, 1970, The Journal of urology.

Management of retroperitoneal recurrences. Seminoma and nonseminoma.

J. Donohue, J. Donohue, R. Foster, 1994, The Urologic clinics of North America.

High-intensity focused ultrasound in the treatment of prostatic disease.

J P Donohue, F. Fry, N. Sanghvi, 1993, European urology.

Review of delayed orchiectomy in patients with disseminated testis tumors.

L. Einhorn, S. Williams, B. Snow, 1983, The Journal of urology.

Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.

P. Albers, T. Ulbright, J. Donohue, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Retroperitoneal lymph node dissection in testicular cancer.

J. Donohue, R. Foster, N. Jacobsen, 2007, Surgical oncology clinics of North America.

The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection.

G. Sledge, L. Rubin, J. Donohue, 1994, The Journal of urology.

Fertility in Nerve-Sparing RPLND

J. Donohue, R. Foster, 1994 .

The role of retroperitoneal surgery in testis cancer.

J. Donohue, H. Leisinger, 2002, Critical reviews in oncology/hematology.

Nerve-sparing retroperitoneal lymphadenectomy.

J. Donohue, R. Foster, 1990, The Urologic clinics of North America.

Metastatic pathways of nonseminomatous germ cell tumors.

J. Donohue, 1984, Seminars in urology.

Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

J. Habbema, E. Steyerberg, S. Fosså, 1996, British Journal of Cancer.

Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection

P. Albers, T. Ulbright, J. Donohue, 2004, World Journal of Urology.

Malignant sex cord-stromal tumor of testis.

J. Eble, J. Donohue, M. T. Hull, 1984, The Journal of urology.

Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage a nonseminomatous testicular germ cell tumor at low risk for occult metastasis

T. Ulbright, J. Donohue, R. Foster, 1995, Cancer.

Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?

Liang Cheng, J. Donohue, R. Bihrle, 2005, The Journal of urology.

Stage II nonseminomatous germ-cell testicular tumors — the Indiana experience and risk-benefit analysis

J. Donohue, R. Bihrle, R. Foster, 1994, World Journal of Urology.

Outcome Analysis for Patients with Persistent Non-Seminomatous Germ Cell Tumour in Post-Chemotherapy Retroperitoneal Lymph Node Dissections

T. Ulbright, L. Einhorn, P. Loehrer, 1994 .

Surgical treatment of clinical stage A nonseminomatous testis cancer.

J. Donohue, R. Foster, 1992, Seminars in oncology.

Hypogonadism in chromatin-negative phenotypic male subjects.

J. Donohue, 1970, The Journal of urology.

Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.

J. Donohue, R. Bihrle, R. Foster, 1991, Urologia internationalis.

What is the appropriate follow-up after treatment?

M. Jewett, J. Donohue, R. Foster, 1996, Seminars in urologic oncology.

High-intensity focused ultrasound in the treatment of prostatic tissue.

J P Donohue, F. Fry, N. Sanghvi, 1994, Urology.

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.

D. Burstein, Yu‐Nien Sun, C. Banfield, 2011, Arthritis research & therapy.

Correlation of clonogenic growth with histologic diagnosis after resection of residual tissue following chemotherapy for nonseminomatous testis cancer.

D. V. Von Hoff, L. Einhorn, M. Sarosdy, 1989, Urology.

Testicular cancer: innovations in diagnosis and treatment.

J. Donohue, R. Rowland, 1988, Seminars in urology.

Hypogandotropic hypogonadism with anosmia: the Kallmann syndrome.

R. N. Dexter, J. Donohue, D. Bixler, 1971, Birth defects original article series.

Renal vascular hypertension. Surgery vs. dilation.

M. Weinberger, J. Donohue, E. Klatte, 1986, Nephron.